R&D The reasoning problem In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.
Digital Veeva Agentic Commercial: Evidence‑led AI for pharma Veeva's Commercial Cloud aims to deliver the right medicines to more patients.
R&D Human behaviour in cancer screening trials: A variable that ... Behavioural phenomena are particularly consequential in screening and prevention research in oncology.
R&D Regulatory setback or scientific signal? The case for human-... Exploring a systemic challenge in translating biological promise into reliable human efficacy and safety.
Digital A well-kept secret: Applying IEPs to accelerate digital heal... Akira Endo discovered mevastatin, a cholesterol-lowering breakthrough molecule in 1973.
Market Access Do better: The message to the industry from an analysis of c... Dr Leeza Osipenko and colleagues analysed the quality of clinical evidence submitted by companies to NICE technology appraisals (TAs) over the last 20 years.
News Ex-BioNTech execs launch 'AI-native' cancer company Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
